Valuation Models of Spectrum Pharmaceuticals, Inc.
Download as PDF
Ziyi Wang, Anxuelun Hu, Yuxiang Yao, Jingjian Lu, Yuhan Peng
Spectrum Pharmaceuticals, Inc. is a biopharma company, with a primary strategy comprised of acquiring, developing, and commercializing a broad and diverse pipeline of clinical and commercial products. This essay aims at evaluating this company using both the absolute valuation model and the relative valuation model. Advantages and drawbacks of these models will also be discussed.
FCFF valuation model, Price-to-sales valuation model, stock price